Data as of Mar 14
| -0.2399 / -1.65%|
The 1 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +40.25% increase from the last price of 14.26.
The current consensus among 1 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.